The tangled amyloid and tau proteins that accumulate in the aging brains of people with Alzheimer’s have been a major focus for drug developers…
Scientists have largely focused on the buildup of beta-amyloid as one of the major drivers of Alzheimer’s disease, but more and more research is…
As research into Alzheimer’s advances, scientists are shifting their focus from beta-amyloid accumulation to inflammation as a main driver of the disease. In a…
In 2015, drug manufacturer Pfizer discovered that their drug Enbrel (etanercept), an anti-inflammatory used to treat rheumatoid arthritis, appeared to lower the risk of…
Previous evidence that Alzheimer’s could be prevented with an over-the-counter anti-inflammatory drug like Aspirin was refuted by a new study. Researchers have long known…
It hasn’t been a great year for Alzheimer’s drugs—or really a great decade, even. The most recent Phase 3 trial cancellation was a study…
While it might sound like a New Age dream that a shrub known as “holy herb” from California could help treat Alzheimer’s, it’s not so…
Sign up for a weekly digest of the latest research on Alzheimer’s and brain health.
Follow us